It was concluded that the DRB1*13 was decreased and DRB1*04 was increased in Iranian ALL patients which can be suggested as protective and susceptible alleles during ALL progression, respectively [135]. The gene discussed is HLA-DRB1; the disease is acute lymphoblastic leukemia.